Zobrazeno 1 - 10
of 952
pro vyhledávání: '"Moscarella E"'
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 14, Pp 1435-1447 (2021)
Gaetano Licata,1 Camila Scharf,1 Andrea Ronchi,2 Sebastiano Pellerone,1 Giuseppe Argenziano,1 Pasquale Verolino,3 Elvira Moscarella1 1Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Van
Externí odkaz:
https://doaj.org/article/2cbc602519fd43b8ae954066bb84a9d0
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 14, Pp 395-406 (2021)
Elvira Moscarella,1 Gabriella Brancaccio,1 Giulia Briatico,1 Andrea Ronchi,2 Simonetta Piana,3 Giuseppe Argenziano1 1Dermatology Unit, University of Campania, Naples, Italy; 2Pathology Unit, University of Campania, Naples, Italy; 3Pathology Unit, Azi
Externí odkaz:
https://doaj.org/article/7fd18cb289974b89a38b0b2c7db45e45
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
In Actas Dermo-Sifiliográficas (English Edition) November 2017 108(9):844-851
Autor:
Chernyshov, P. V., Finlay, A. Y., Tomas‐Aragones, L., Tognetti, L., Moscarella, E., Pasquali, P., Manolache, L., Pustisek, N., Svensson, A., Marron, S. E., Bewley, A., Salavastru, C., Suru, A., Koumaki, D., Linder, D., Abeni, D., Augustin, M., Blome, C., Salek, S. S., Evers, A. W. M.
Publikováno v:
Journal of the European Academy of Dermatology & Venereology; Feb2024, Vol. 38 Issue 2, p254-264, 11p
Autor:
Briatico G., Brancaccio G., Scharf C., Di Brizzi E. V., Pellerone S., Caccavale S., Giorgio C. M., Procaccini E. M., Moscarella E., Argenziano G.
Publikováno v:
Dermatology Practical & Conceptual. :e2023151
Introduction:5-fluorouracil (5-FU) is one of the most effective topical treatments for actinic keratosis (AK). A new 4% formulation of 5-FU was recently approved in Europe. Objectives:This study aimed at evaluating 4% 5-FU cream safety and effectiven
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e543ff43580cc3e8540b439d956223
https://doi.org/10.5826/dpc.1302a151
https://doi.org/10.5826/dpc.1302a151
Autor:
Povilaite I., Argenziano G., Babino G., Conforti C., Moscarella E., Pagliuca F., Ronchi A., Zalaudek I., Agozzino M.
Publikováno v:
Dermatology practicalconceptual. 12(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dcc2407b68d611fb55c2853729d62f2
https://pubmed.ncbi.nlm.nih.gov/36534581
https://pubmed.ncbi.nlm.nih.gov/36534581
Autor:
Cavallari, I., Maddaloni, E., Gragnano, F., Patti, G., Antonucci, E., Calabro, P., Cirillo, P., Gresele, P., Palareti, G., Pengo, V., Pignatelli, P., Marcucci, R., Moscarella, E., Cesaro, A., Grossi, G., Berteotti, M., De Rosa, G., Taglialatela, V., Digitale, L., Denas, G., Pastori, D., del Pinto, M., Fierro, T.
Publikováno v:
Internal and Emergency Medicine. 16:1583-1591
The risk of ischemic events carried by different clusters of type 2 diabetes mellitus (DM) in the setting of secondary prevention is not definite and the association between DM and bleeding complications is controversial. We explored these issues in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01ad92ea990eee2a3d7c1addeca5006e
https://doi.org/10.1007/s11739-021-02640-z
https://doi.org/10.1007/s11739-021-02640-z
Autor:
Gragnano F., Moscarella E., Calabro P., Cesaro A., Pafundi P. C., Ielasi A., Patti G., Cavallari I., Antonucci E., Cirillo P., Pignatelli P., Palareti G., Pelliccia F., Gaudio C., Sasso F. C., Pengo V., Gresele P., Marcucci R., Fimiani F., Vitale R. A., Schiavo A., Conte M., Di Maio D., Pastori D., Menichelli D., Grossi G., Di Serafino L., Taglialatela V., Galiero R., Acierno C., del Pinto M., Gugliemini G.
Optimal dual antiplatelet therapy (DAPT) strategy in high-bleeding risk (HBR) patients presenting with acute coronary syndrome remains debated. We sought to investigate the use of clopidogrel versus ticagrelor in HBR patients with acute coronary synd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::577570dfa444bd7c66aaf254010a13b3
http://hdl.handle.net/11573/1426011
http://hdl.handle.net/11573/1426011
Autor:
Ronchi A., Montella M., Cozzolino I., Argenziano G., Moscarella E., Piccolo V., Iovino F., Troiani T., Alfano R., Errico M. E., D'Onofrio V., Berretta M., Franco R., Zito Marino F., ZITO MARINO, Federica
Publikováno v:
European review for medical and pharmacological sciences. 24(7)
OBJECTIVE: Anaplastic lymphoma kinase (ALK) gene has been demonstrated to be rearranged, mutated or amplified in several haematological and solid tumors. Moreover, the use of ALK inhibitors has recently revolutionized the treatment of ALK-rearranged
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::245508b397b7100348a87298595e7ba5
https://pubmed.ncbi.nlm.nih.gov/32329859
https://pubmed.ncbi.nlm.nih.gov/32329859